Premier Diagnostic Health Services, Inc.
Premier Diagnostic Health Services, Inc. engages in developing and operating diagnostic imaging clinics in Canada and China. It provides advanced imaging technology that improves patient services and outcomes and provides physicians and healthcare professionals with the early and accurate detection of cancer and other diseases. The company provides services utilizing Positron Emission Technology and Magnetic Resonance Imagining technologies, and the establishment of facilities for the commercial production of Health Canada-approved CanTrace fluorodeoxyglucose, the radiopharmaceutical used in PET scanning, for use and sale. The company was founded on July 16, 2010 and is headquartered in Burnaby, Canada.